Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00614094 · ClinicalTrials.gov registry record
Maternal Hypoglycemia and Placental Pathology
A clinical trial, sponsored by Oklahoma State University Center for Health Sciences.
- Completed
- Registry status
- 350
- Enrollment target
NCT00614094: Completed study, sponsored by Oklahoma State University Center for Health Sciences.
NCT00614094 is a clinical trial that has completed, run by Oklahoma State University Center for Health Sciences. The registered enrollment target is 350 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00614094 has completed, sponsored by Oklahoma State University Center for Health Sciences.
- COMPLETED
- Registry status
- 350 participants
- Enrollment target
Study Summary
The purpose of this retrospective pilot study is to assess the association of maternal hypoglycemia during the one hour glucose tolerance test with decreased placental weight and identifiable placental pathology. We hypothesize that a decreased one hour glucose tolerance test is a risk factor for decreased placental weight, an increased fetal to placental weight ratio, and other identifiable placental pathology.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-07 |
What the finished NCT00614094 record still lists
NCT00614094 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00614094 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00614094 about?
NCT00614094 is a clinical study titled "Maternal Hypoglycemia and Placental Pathology". The purpose of this retrospective pilot study is to assess the association of maternal hypoglycemia during the one hour glucose tolerance test with decreased placental weight and identifiable placental pathology. We hypothesize that a decreased one hour glucose tolerance test is a risk factor for de...
What is the current status of trial NCT00614094?
This trial is currently completed. The enrollment target is 350 participants. The study started on 2007-12. Estimated completion is 2008-07.
Who is sponsoring clinical trial NCT00614094?
This trial is sponsored by Oklahoma State University Center for Health Sciences, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia